Cannabis Health Science Studies Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
To utilize this website to your benefit, use any cannabis related key words or phrases including any symptoms, illnesses, or disease. You may also scroll from here.

SPINAL CORD INJURY and cannabis studies completed

A Spinal cord injury (SCI) refers to any injury to the spinal cord that is caused by trauma instead of disease. Five patients with traumatic paraplegia were given oral Delta-9-THC at 35 mg/day in a double blind, 20-day crossover trial.

1974 - Study ~ The perceived effects of marijuana on spinal cord injured males.

1980 - Study ~ Marihuana as a therapeutic agent for muscle spasm or spasticity.

1982 - Study ~ Cannabis effect on spasticity in spinal cord injury.

1986 - Study ~ The effect of delta-9-THC on human spasticity.

1990 - Study ~ Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.

1995 - Study ~ Treatment of spasticity in spinal cord injury with dronabinol, a tetrahydrocannabinol derivative.

1996 - Study ~ The effect of orally and rectally administered delta-9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.

1997 - Study ~ Involvement of Dynorphin B in the Antinociceptive Effects of the Cannabinoid CP55,940 in the Spinal Cord.

1999 - Study ~ Cannabis and cannabinoids: pharmacology and rationale for clinical use.

2001 - Study ~ Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo.

2001 - Study ~ Clinical investigation of delta-9-tetrahydrocannabinol (THC) as an alternative therapy for overactive bladders in spinal cord injury (SCI) patients.

2003 - Study ~ The treatment of spasticity with D9-tetrahydrocannabinol (D9-THC) in patients with spinal cord injury.

2003 - Study ~ Therapeutic potential of cannabinoids in CNS disease.

2004 - Study ~ Are oral cannabinoids safe and effective in refractory neuropathic pain?

2006 - Study ~ Treatments for Chronic Pain in Persons With Spinal Cord Injury: A Survey Study.

2006 - Study ~ Antinociceptive effect of cannabinoid agonist WIN 55,212–2 in rats with a spinal cord injury.

2006 - Study ~ Effects of a Cannabinoid Agonist on Spinal Nociceptive Neurons in a Rodent Model of Neuropathic Pain.

2006 - Study ~ Cannabinoids In Medicine: A Review Of Their Therapeutic Potential.

2006 - Study ~ The treatment of spasticity with Delta(9)-tetrahydrocannabinol in persons with spinal cord injury.

2008 - Study ~ Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury.

2009- Study ~ Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain.

2009 - Study ~ The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function.

2009 - News ~ Medical Marijuana and Whiplash.

2010 - Study ~ Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain.

2010 - Study ~ Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study.

2010 - Study ~ Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.

2010 - Study ~ The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury.

2010 - Study ~ A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury.

2011 - Study ~ Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases.

2011 - Study ~ Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury.

2011- Study ~ Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury.

2011 - Study ~ Spinal Cord Injuries Induce Changes of CB1 Cannabinoid Receptor and C-C Chemokine Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions.

2011 - Study ~ Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury.

2011- Study ~ Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.

2011- Study ~ Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury.

2011 - Study ~ Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury.

2012- Study ~ A Role for the Cannabinoid 1 Receptor in Neuronal Differentiation of Adult Spinal Cord Progenitors in vitro is Revealed through Pharmacological Inhibition and Genetic Deletion.

2012 - Study ~ The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats.

2012 - Study ~ Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery

2012 - Study ~ A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord

2012 - Study ~ The interaction between intrathecal administration of low doses of
palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal
cord IL1-β expression in rats.

2012 - Study ~ Specific inhibition of the JNK pathway promotes locomotor recovery and
neuroprotection after mouse spinal cord injury

2013 - Study ~ Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats

2013 - Study ~ A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury

2013 - Study ~ Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries

2013 - Study ~ Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator

2013 - Study ~ Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats.

2013 - Study ~ Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury.